Inventor
KIM SANG-JAE
KR69 patents
⚠️ This page may combine multiple inventors who share the name “KIM SANG-JAE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GEMVAX & KAEL CO LTD
38 patentsUS9540419B2Jan 10, 2017
Anti-inflammatory peptides and composition comprising the same
GEMVAX & KAEL CO LTD20 citations96
US9902945B2Feb 27, 2018
Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
GEMVAX & KAEL CO LTD12 citations93
US9572900B2Feb 21, 2017
Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
GEMVAX & KAEL CO LTD12 citations93
US9572858B2Feb 21, 2017
Composition for treating and preventing benign prostatic hyperplasia
GEMVAX & KAEL CO LTD20 citations93
US10039811B2Aug 7, 2018
Anti-inflammatory peptides and composition comprising the same
GEMVAX & KAEL CO LTD10 citations92
US9527888B2Dec 27, 2016
Anti-inflammatory peptides and composition comprising the same
GEMVAX & KAEL CO LTD11 citations92
US11369665B2Jun 28, 2022
Anti-inflammatory peptides and composition comprising the same
GEMVAX & KAEL CO LTD4 citations84
US10960056B2Mar 30, 2021
Anti-inflammatory peptides and composition comprising the same
GEMVAX & KAEL CO LTD4 citations84
US10888606B2Jan 12, 2021
Anti-inflammatory peptides and compositions comprising the same
GEMVAX & KAEL CO LTD2 citations84
US10206981B2Feb 19, 2019
Anti-inflammatory peptides and composition comprising the same
GEMVAX & KAEL CO LTD3 citations84
US10034922B2Jul 31, 2018
Peptide having angiogenesis inhibitory activity and composition containing same
GEMVAX & KAEL CO LTD7 citations84
US9937240B2Apr 10, 2018
Peptide having fibrosis inhibitory activity and composition containing same
GEMVAX & KAEL CO LTD7 citations84
US9757473B2Sep 12, 2017
Cell-penetrating peptide and conjugate comprising same
GEMVAX & KAEL CO LTD12 citations84
US9631184B2Apr 25, 2017
Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
GEMVAX & KAEL CO LTD11 citations84
US12171812B2Dec 24, 2024
Anti-inflammatory peptides and composition comprising the same
GEMVAX & KAEL CO LTD0 citations73
US12168039B2Dec 17, 2024
Anti-inflammatory peptides and composition comprising the same
GEMVAX & KAEL CO LTD0 citations73
US11857607B2Jan 2, 2024
Anti-inflammatory peptides and composition comprising the same
GEMVAX & KAEL CO LTD0 citations73
US11773381B2Oct 3, 2023
Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
GEMVAX & KAEL CO LTD1 citations73
US11622998B2Apr 11, 2023
Anti-inflammatory peptides and composition comprising the same
GEMVAX & KAEL CO LTD1 citations73
US10967000B2Apr 6, 2021
Cell-penetrating peptide, conjugate comprising same and composition comprising same
GEMVAX & KAEL CO LTD2 citations73
US10822595B2Nov 3, 2020
Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
GEMVAX & KAEL CO LTD1 citations73
US10676507B2Jun 9, 2020
Peptide and composition containing the same for anti-inflammation, anti-fibrosis, wound healing, and anticancer treatment
GEMVAX & KAEL CO LTD4 citations73
US10383926B2Aug 20, 2019
Biological markers useful in cancer immunotherapy
GEMVAX & KAEL CO LTD3 citations73
US10245327B2Apr 2, 2019
Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
GEMVAX & KAEL CO LTD2 citations73
US9907837B2Mar 6, 2018
Composition for preventing or treating cachexia
GEMVAX & KAEL CO LTD2 citations73
US9907838B2Mar 6, 2018
Composition and methods for treating ischemic damage
GEMVAX & KAEL CO LTD3 citations73
US9730984B2Aug 15, 2017
Composition for preventing or treating rheumatoid arthritis
GEMVAX & KAEL CO LTD2 citations73
US11844845B2Dec 19, 2023
Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
GEMVAX & KAEL CO LTD0 citations63
US11077163B2Aug 3, 2021
Peptide for treating ocular diseases and composition for treating ocular diseases comprising same
GEMVAX & KAEL CO LTD0 citations63
US11058744B2Jul 13, 2021
Composition for treating prostate cancer
GEMVAX & KAEL CO LTD0 citations63
US11015179B2May 25, 2021
Peptide having anti-viral effect and composition containing same
GEMVAX & KAEL CO LTD0 citations63
US10463708B2Nov 5, 2019
Peptide for treating ocular diseases and composition for treating ocular diseases comprising same
GEMVAX & KAEL CO LTD1 citations63
US12156902B2Dec 3, 2024
Anti-inflammatory peptides and composition comprising the same
GEMVAX & KAEL CO LTD0 citations62
US11905536B2Feb 20, 2024
Anti-inflammatory peptides and composition comprising the same
GEMVAX & KAEL CO LTD0 citations59
US11098294B2Aug 24, 2021
Anti-inflammatory peptides and composition comprising same
GEMVAX & KAEL CO LTD1 citations59
US10835582B2Nov 17, 2020
Peptide for preventing hearing loss, and composition comprising same
GEMVAX & KAEL CO LTD0 citations52
US10662223B2May 26, 2020
Composition for organ, tissue, or cell transplantation, kit, and transplantation method
GEMVAX & KAEL CO LTD0 citations52
US10561703B2Feb 18, 2020
Method of modulating sex hormone levels using a sex hormone secretion modulator
GEMVAX & KAEL CO LTD0 citations52
SAMSUNG DISPLAY CO LTD
5 patentsUS9250473B2Feb 2, 2016
Polarizing plate and display apparatus having the same
SAMSUNG DISPLAY CO LTD3 citations73
US12189429B2Jan 7, 2025
Display device
SAMSUNG DISPLAY CO LTD0 citations62
US11775008B2Oct 3, 2023
Foldable display device
SAMSUNG DISPLAY CO LTD0 citations62
US11672084B2Jun 6, 2023
Foldable display device
SAMSUNG DISPLAY CO LTD1 citations62
US10433436B2Oct 1, 2019
Flexible display device
SAMSUNG DISPLAY CO LTD1 citations58
JAPAN SCIENCE & TECH CORP
2 patentsKIM SANG-JAE
1 patentSAMSUNG ELECTRONICS CO LTD
1 patentKIM TAEHO
1 patentCHO SANG-NAE
1 patentLG ELECTRONICS INC
1 patentShowing the top 50 of 69 patents by PatentIndex Score.